Business Shire Bids to Buy Baxalta Published August 4, 2015 • Updated on August 4, 2015 at 9:01 pm Shire Pharmaceuticals has placed a bid to buy Baxalta for $30 billion. Don Seiffert of the Boston Business Journal joined necn to discuss. Read the full BBJ article here.
